Immune thrombocytopenia (ITP) is an acquired disorder characterized by isolated thrombocytopenia with a peripheral blood platelet count <100 × 109/L in the absence of any obvious initiating or underlying cause. It is a diagnosis of exclusion.
It can be idiopathic or secondary (i.e. due to a connective tissue disease, lymphoma etc). Auto-antibodies have been identified against specific platelet glycoproteins.
List the therapies that can be used in ITP.